Vivos Therapeutics, Inc. · Brief

Next report

21 days

Nov 24 · after closeest.Q3 FY26

Expected move

No implied move.

No reported quarters.

Nov 24 report · est.

—

VVOS report session

No linked exposure.

Oct 198-KMaterial agreement: Mutual Stock Purchase and Asset Exchange Agreement with SOD Sciences, Inc.Source

Oct 158-KMaterial agreement: Mutual Stock Purchase and Asset Exchange Agreement with SOD Sciences, Inc.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.